SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-14-375209
Filing Date
2014-10-17
Accepted
2014-10-17 17:25:03
Documents
7

Document Format Files

Seq Description Document Type Size
1 425 d806344d425.htm 425 32028
2 GRAPHIC g8063441.jpg GRAPHIC 270007
3 GRAPHIC g8063442.jpg GRAPHIC 291173
4 GRAPHIC g8063443.jpg GRAPHIC 293766
5 GRAPHIC g8063444.jpg GRAPHIC 295141
6 GRAPHIC g8063445.jpg GRAPHIC 309421
7 GRAPHIC g806344g35s97.jpg GRAPHIC 289564
  Complete submission text file 0001193125-14-375209.txt   2444451
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-14956 | Film No.: 141162550
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425